Given that the lockdown measures taken so as to diminish the dissemination of the COVID-19 pandemic are likely to create major mental disorders such as obsessive-compulsive disorder (OCD), the present study was conducted aiming to evaluate the prevalence of OCD and cognitive errors among young people during the outbreak of coronavirus disease 2019. The present study is a descriptive, cross-sectional study in which a total of 150 young people aged 13 to 19 were randomly included. Maudsley Obsessive-Compulsive Inventory Questionnaire (MOCI) and Cognitive Error Questionnaire (CEQ) were completed, and then their results were analyzed by SPSS 22 software. The results revealed that 67.3% of the subjects who were evaluated may have demonstrated OCD symptomatology. The prevalence of obsessive-compulsive disorder symptoms in women was slightly higher than in men (72.1 compared to 60.3%). Likewise, the test results indicated that there was a significant difference between obsessive-compulsive disorder symptom in men and women (p = .001). There was also a significant difference between the two groups with OCD symptoms and without OCD symptoms in all the components of cognitive errors (p = .001). To the authors’ best of knowledge, this is the first study that has evaluated OCD symptoms at the time of COVID-19 prevalence. The findings suggest the need to enhance the prevention of relapse during social restrictions as well as to develop other strategies including online consultation and digital psychiatric management.
This study aimed to evaluate the efficacy of personalized nursing care. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically searched multiple databases and search engines, including PubMed, Scopus, ProQuest, CINAHL, and Google Scholar, for articles published between 2011 and September 31, 2022. To evaluate the quality of the incorporated studies, we utilized established assessment tools, including the CONSORT checklist, STROBE statement, and Kmet standard criteria. A qualitative narrative synthesis approach was employed for data synthesis. The systematic review included 24 studies involving 5428 participants. Across these studies, a consistent positive correlation was found between personalized care administered by nurses and participant satisfaction. Patients receiving personalized care experienced reduced negative emotional symptoms, suggesting potential therapeutic benefits extending beyond physical health outcomes. Health guidance education, individualized healthcare plan and dedicated nursing team were the examples of personalized nursing interventions. The results underlined the importance of personalized nursing in delivering essential services. Personalized nursing aims to improve the quality of care by adapting it to each individual’s unique needs and characteristics. Patient or public contribution: This study did not include contributions from patients or the public. Systematic Review Registration: CRD42022367814.
1 December 2024 in Clinical and Experimental Dental Research
Objectives: This study aimed to compare the effects of local and systemic metronidazole in patients with chronic periodontitis.Materials and Methods: In this randomized clinical study, 30 patients (3 teeth per patient) were treated in three groups: scaling and root planing (SRP) treatment alone, metronidazole tablet as adjunctive treatment, and metronidazole gel as adjunctive treatment. BOP (bleeding on probing), PPD (pocket probing depth), and CAL (clinical attachment level) data were collected at the beginning and 3 months later. Collected data were tested by Wilcoxon and Kruskal–Wallis tests.Results: BOP, CAL, and PPD levels were significantly different at the beginning of treatment and after 3 months, and this was true for all treatments. BOP, CAL, and PPD levels did not differ significantly between the three groups after the treatment (p > 0.05).Conclusion: The effectiveness of these methods was all equal and SRP is still considered as the gold standard in the treatment of periodontal diseases. Further studies are needed to confirm the findings. Chronic periodontitis is a progressive disease that can cause tooth loss. The accepted treatment is SRP. Antibiotics used systemically can penetrate the depth of the periodontal pockets but have several side effects. Hence, using a less complicated medicinal form as a topical gel as adjunctive therapy in treating chronic periodontitis can be more effective.Trial Registration: Iranian clinical trial https://en.irct.ir/: IRCT20210408050898N1
1 January 2024 in Investigación y Educación en Enfermería
Objective: to evaluate the association of Orem self-care model improvement of symptoms and quality of life in patients with diabetes. Methods. A scoping reviewwas carried on bibliographic databases: PubMed-Medline, Scopus, SID and Magiran. The inclusion criteria encompassed studies examining the impact of the Orem self-care model on diabetic patients. Studies considered for inclusion needed to have full-text availability and be written in either English or Persian, with key words including “Models”, “Nursing”, “Quality of Life”, and “Diabetes Mellitus”. CONSORT checklist and STROBE statement were selected for quality assessment. Results. A total of 9 studies were included, all using quantitative methodology and focusing on adults or older adults. The majority of articles focused on quality of life and diabetic symptoms. 8 studies showed positive outcomes after implementation of the model. The findings indicate that this model led to an enhanced level of self-efficacy, improved quality of life, and better self-care practices among diabetic patients. Conclusion. Orem self-care model can reduce the diabetic symptoms and improve the quality of life, self-efficacy and self-care in these patients.
Coronavirus disease 2019 (COVID-19), a new type and rapidly spread viral pneumonia, is now producing an outbreak of pandemic proportions. The clinical features and laboratory results of different age groups are different due to the general susceptibility of the disease. The laboratory findings of COVID-19 in pregnant women are also conflicting. Para-clinical investigations including laboratory tests and radiologic findings play an important role in early diagnosis and treatment monitoring of severe acute respiratory syndrome and coronavirus-2 (SARS-CoV-2). The majority of previous reports on the SARS-CoV-2 laboratory results were based on data from the general population and limited information is available based on age difference and pregnancy status. This review aimed to describe the COVID-19 laboratory findings in neonates, children, adults, elderly and pregnant women altogether for the first time. The most attracting and reliable markers of COVID-19 in patients were: normal C-reactive protein (CRP) and very different and conflicting laboratory results regardless of clinical symptoms in neonates, normal or temporary elevated CRP, conflicting WBC count results and procalcitonin elevation in children, lymphopenia and elevated lactate dehydrogenase (LDH) in adult patients, lymphopenia and elevated CRP and LDH in the elderly people and high CRP, leukocytosis and elevated neutrophil ratio in pregnant women.
Over the past 20 years, a series of major outbreaks of acute respiratory infections such as 2009 influenza A (H1N1) and the 2019 new coronavirus disease (2019-nCoV) have arisen and posed a major threat to the health of the global population. The outbreak of coronavirus calls to mind the pandemics that have instilled great fear in our memories such as severe acute respiratory syndrome (SARS), Zika virus (ZIKV), Middle East respiratory syndrome (MERS), and H1N1 flu. The 2 prominent outbreaks, 2019-nCoV and H1N1, have markedly affected humans. In this study, therefore, we compared some clinical, demographic, and laboratory findings to determine the differences between H1N1 influenza and coronavirus disease-2019 (COVID-19) to suggest the appropriate drug therapeutic approaches. Subsequent to the inclusion of 4 available studies, which presented all the required data, the findings and results were compared, showing fever and cough as the most prevalent clinical indications of both H1N1 influenza and 2019-nCoV diseases. With respect to the laboratory findings, both 2019-nCoV and H1N1 patients showed leukopenia as the main laboratory findings. Taken together, since similar diagnostic methods are used for H1N1 and 2019-nCoV patients and they have the same clinical and laboratory features, it is safe to say that lopinavir/ritonavir and nucleoside analogues could be drug treatment options for patients suffering from 2019-nCoV. However, given the current urgent condition, the primary and main intervention procedure is controlling the infection so as to halt the dissemination of COVID-19. It is recommended, however, that the providers of public health care maintain a close watch on the situation, because the more information we obtain about this new virus and the ensuing epidemic, the faster we can react.